Vitiligo-like lesions and immune checkpoint inhibition therapy: is it truly an adverse event exclusive to patients with melanoma?

  1. Rodríguez-Lomba, E.
  2. Molina-López, I.
  3. Suárez-Fernández, R.
  4. Baniandrés-Rodríguez, O.
Aldizkaria:
Clinical and Experimental Dermatology

ISSN: 1365-2230,  0307-6938

Argitalpen urtea: 2018

Alea: 43

Zenbakia: 5

Orrialdeak: 598-599

Mota: Artikulua

DOI: 10.1111/CED.13382 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus